by Inari | May 18, 2020 | News, News, News, News, News, News
IRVINE, CALIFORNIA — May 18, 2020 /PRNewswire/ — Inari Medical, Inc. (“Inari”), a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, today announced that it...
by Inari | Jan 28, 2020 | Uncategorized
IRVINE, CALIFORNIA – January 28, 2020 — Inari Medical, Inc., a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, today announced the appointment of Cynthia Lucchese...
by Inari | Nov 8, 2019 | Uncategorized
IRVINE, CALIFORNIA – November 6, 2019 — Inari Medical, Inc. today announced the presentation of early outcomes from the ClotTriever Outcomes Registry (“CLOUT”) using the ClotTriever Mechanical Thrombectomy System for treatment of acute and chronic lower...
by Inari | Jul 8, 2019 | Uncategorized
IRVINE, CALIFORNIA – July 2, 2019 — Inari Medical, Inc. announced today that the company has appointed Thomas M. Tu, M.D. as Chief Medical Officer. Dr. Tu is a pioneer in definitive catheter-based treatment of pulmonary embolism (PE). He was the lead author in...
by Inari | May 7, 2019 | Uncategorized
IRVINE, CALIFORNIA – May 7, 2019 — Inari Medical, Inc. announced today the publication of its 106-patient prospective multicenter FlowTriever Mechanical Pulmonary Embolectomy (FLARE) study for the treatment of intermediate-risk pulmonary embolism (PE). The...
by Inari | Oct 1, 2018 | Uncategorized
IRVINE, CALIFORNIA – September 27, 2018 — Inari Medical, Inc. announced today the enrollment of the first patient in the ClotTriever Outcomes Registry (“CLOUT”) using the ClotTriever® Thrombectomy System. CLOUT is a 500-patient prospective, multicenter,...